Filing Details

Accession Number:
0000874015-17-000013
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-01-18 18:36:45
Reporting Period:
2017-01-15
Filing Date:
2017-01-18
Accepted Time:
2017-01-18 18:36:45
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
874015 Ionis Pharmaceuticals Inc IONS Pharmaceutical Preparations (2834) 330336973
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
897667 T Stanley Crooke C/O Ionis Pharmaceuticals, Inc.
2855 Gazelle Court
Carlsbad CA 92010
Chairman And Ceo Yes Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2017-01-15 5,547 $0.00 30,576 No 4 M Direct
Common Stock Disposition 2017-01-17 3,008 $46.29 27,568 No 4 S Direct
Common Stock Acquisiton 2017-01-15 7,812 $0.00 35,380 No 4 M Direct
Common Stock Disposition 2017-01-17 4,236 $46.29 31,144 No 4 S Direct
Common Stock Acquisiton 2017-01-15 6,875 $0.00 38,019 No 4 M Direct
Common Stock Disposition 2017-01-17 3,728 $46.29 34,291 No 4 S Direct
Common Stock Acquisiton 2017-01-15 8,133 $0.00 42,424 No 4 M Direct
Common Stock Disposition 2017-01-17 4,410 $46.29 38,014 No 4 S Direct
Common Stock Acquisiton 2017-01-15 416 $0.00 2,586 No 4 M Indirect By wife
Common Stock Disposition 2017-01-17 163 $46.29 2,423 No 4 S Indirect By wife
Common Stock Acquisiton 2017-01-15 354 $0.00 2,777 No 4 M Indirect By wife
Common Stock Disposition 2017-01-17 139 $46.29 2,638 No 4 S Indirect By wife
Common Stock Acquisiton 2017-01-15 363 $0.00 3,001 No 4 M Indirect By wife
Common Stock Disposition 2017-01-17 142 $46.29 2,859 No 4 S Indirect By wife
Common Stock Acquisiton 2017-01-15 334 $0.00 3,193 No 4 M Indirect By wife
Common Stock Disposition 2017-01-17 131 $46.29 3,062 No 4 S Indirect By wife
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Direct
No 4 S Direct
No 4 M Indirect By wife
No 4 S Indirect By wife
No 4 M Indirect By wife
No 4 S Indirect By wife
No 4 M Indirect By wife
No 4 S Indirect By wife
No 4 M Indirect By wife
No 4 S Indirect By wife
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Restricted Stock Units Acquisiton 2017-01-15 27,168 $0.00 27,168 $0.00
Common Stock Restricted Stock Units Acquisiton 2017-01-15 2,692 $0.00 2,692 $0.00
Common Stock Restricted Stock Units Disposition 2017-01-15 5,547 $0.00 5,547 $0.00
Common Stock Restricted Stock Units Disposition 2017-01-15 7,812 $0.00 7,812 $0.00
Common Stock Restricted Stock Units Disposition 2017-01-15 6,875 $0.00 6,875 $0.00
Common Stock Restricted Stock Units Disposition 2017-01-15 8,133 $0.00 8,133 $0.00
Common Stock Restricted Stock Units Disposition 2017-01-15 416 $0.00 416 $0.00
Common Stock Restricted Stock Units Disposition 2017-01-15 354 $0.00 354 $0.00
Common Stock Restricted Stock Units Disposition 2017-01-15 363 $0.00 363 $0.00
Common Stock Restricted Stock Units Disposition 2017-01-15 334 $0.00 334 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
27,168 No 4 A Direct
2,692 No 4 A Indirect
0 No 4 M Direct
7,812 No 4 M Direct
13,750 No 4 M Direct
24,397 No 4 M Direct
0 No 4 M Indirect
354 No 4 M Indirect
724 No 4 M Indirect
999 No 4 M Indirect
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 725,391 Indirect By trust
Footnotes
  1. Acquired pursuant to vesting and release of shares pursuant to a Restricted Stock Unit award granted on January 30, 2013.
  2. The sale was made pursuant to an automatic sale to cover the required tax withholding obligations pursuant to the 2011 Equity Incentive Plan Restricted Stock Unit Agreement and Grant Notice, dated January 30, 2013.
  3. Acquired pursuant to vesting and release of shares pursuant to a Restricted Stock Unit award granted on January 15, 2014.
  4. The sale was made pursuant to an automatic sale to cover the required tax withholding obligations pursuant to the 2011 Equity Incentive Plan Restricted Stock Unit Agreement and Grant Notice, dated January 15, 2014.
  5. Acquired pursuant to vesting and release of shares pursuant to a Restricted Stock Unit award granted on January 15, 2015.
  6. The sale was made pursuant to an automatic sale to cover the required tax withholding obligations pursuant to the 2011 Equity Incentive Plan Restricted Stock Unit Agreement and Grant Notice, dated January 15, 2015.
  7. Acquired pursuant to vesting and release of shares pursuant to a Restricted Stock Unit award granted on January 15, 2016.
  8. The sale was made pursuant to an automatic sale to cover the required tax withholding obligations pursuant to the 2011 Equity Incentive Plan Restricted Stock Unit Agreement and Grant Notice, dated January 15, 2016.
  9. Acquired pursuant to vesting and release of shares pursuant to a Restricted Stock Unit award granted on January 15, 2013.
  10. The sale was made pursuant to an automatic sale to cover the required tax withholding obligations pursuant to the 2011 Equity Incentive Plan Restricted Stock Unit Agreement and Grant Notice, dated January 15, 2013.
  11. Each Restricted Stock Unit represents a contingent right to receive one share of Ionis common stock, or its equivalent cash value.
  12. Grant 1/15/2017 to reporting person of Restricted Stock Units under the Ionis Pharmaceuticals, Inc. 2011 Equity Incentive Plan. Restricted Stock Units vest in four equal annual installments, the first installment vesting on January 15, 2018. Upon vesting, the restricted stock units will be paid out in whole shares of Ionis common stock or cash as may be determined by the Company. The RSU shall be fully vested on January 15, 2021. The RSU is vested as to 0 shares on January 15, 2017.
  13. Grant 1/15/2017 to reporting person's wife of Restricted Stock Units under the Ionis Pharmaceuticals, Inc. 2011 Equity Incentive Plan. Restricted Stock Units vest in four equal annual installments, the first installment vesting on January 15, 2018. Upon vesting, the restricted stock units will be paid out in whole shares of Ionis common stock or cash as may be determined by the Company. The RSU shall be fully vested on January 15, 2021. The RSU is vested as to 0 shares on January 15, 2017.
  14. Restricted Stock Units vest in four equal annual installments. Upon vesting, the restricted stock units will be paid out in whole shares of Ionis common stock or cash as may be determined by the Company.